Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma
J Cancer Res Clin Oncol
.
2022 Jul;148(7):1709.
doi: 10.1007/s00432-022-04062-6.
Authors
Ofer Margalit
#
1
2
,
Shun Yu
#
3
4
,
Einat Shacham-Shmueli
5
6
,
Gal Strauss
5
6
,
Yu-Xiao Yang
3
7
,
Yaacov R Lawrence
5
6
8
,
Kim A Reiss
8
,
Talia Golan
5
6
,
Naama Halpern
5
6
,
Dan Aderka
5
6
,
Bruce Giantonio
9
,
Ronac Mamtani
3
8
,
Ben Boursi
5
6
3
Affiliations
1
Institute of Oncology, Sheba Medical Center, Tel-Hashomer, 52621, Ramat Gan, Israel. ofer.margalit@sheba.health.gov.il.
2
Tel-Aviv University, Tel-Aviv, Israel. ofer.margalit@sheba.health.gov.il.
3
Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
4
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
5
Institute of Oncology, Sheba Medical Center, Tel-Hashomer, 52621, Ramat Gan, Israel.
6
Tel-Aviv University, Tel-Aviv, Israel.
7
Division of Gastroenterology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
8
Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
9
Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
#
Contributed equally.
PMID:
35652957
DOI:
10.1007/s00432-022-04062-6
No abstract available
Publication types
Published Erratum